SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-10-004637
Filing Date
2010-11-12
Accepted
2010-11-12 16:30:35
Documents
5
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0910_soligenix.htm 10-Q 674433
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO EXCHANGE ACT RULE 13(A)-14( f10q0910ex31i_soligenix.htm EX-31.1 14706
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO EXCHANGE ACT RULE 13(A)-14( f10q0910ex31ii_soligenix.htm EX-31.2 13926
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 OF THE SARBANES f10q0910ex32i_soligenix.htm EX-32.1 6619
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 OF THE SARBANES f10q0910ex32ii_soligenix.htm EX-32.2 6418
  Complete submission text file 0001213900-10-004637.txt   717847
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16929 | Film No.: 101187083
SIC: 2834 Pharmaceutical Preparations